A transcriptomic severity classifier IMX-SEV-3b to predict mortality in ICU patients with COVID-19 - Inflammatix

Skip to main content Skip to footer

Home
Triverity
Education
Evidence
- Publications
- Abstracts
Pipeline
News
Careers
About
Reach out

Home
Triverity
Education
Evidence
- Publications
- Abstracts
Pipeline
News
Careers
About
Reach out

Daenen, K. et al. J. Clin. Med. Sep 2023.

© Copyright 2025, Inflammatix, Inc. All Rights Reserved | Terms & Conditions | Privacy & Cookies Statement

Inflammatix, TriVerity, Myrna, RespVerity, and BacVerity are trademarks of Inflammatix, Inc.